NCT01032889View on ClinicalTrials.gov

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Moderate or Severe Submental Fullness
Interventions
DRUG

Deoxycholic acid injection

DRUG

Placebo

Phosphate buffered saline placebo for injection

Trial Locations (10)

35205

Investigational Site, Birmingham

55432

Investigational Site, Fridley

60563

Investigational Site, Naperville

63141

Investigational Site, St Louis

68144

Investigational Site, Omaha

75093

Investigational Site, Plano

90210

Investigational Site, Beverly Hills

90212

Investigational Site, Beverly Hills

94115

Investigational Site, San Francisco

02467

Investigational Site, Chestnut Hill

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY